Natalizumab long-term therapy for relapsing MS in clinical routine: Final results of the prospective observational multicenter study Tysabri® 24 plus

Authors
Category Primary study
JournalJournal of the Neurological Sciences
Year 2013
This article has no abstract
Epistemonikos ID: 33c17e7638287f1b0a781a432a127ec9a459849c
First added on: Feb 05, 2025